The only update for patients with stage IV NSCLC without driver alterations is that patients who have HER2-overexpressing (IHC 3+) disease and good performance status can receive trastuzumab ...

BNT327, a PD L1/VEGF antibody, belongs to a class of next-generation immunotherapies hoping to beat out Keytruda.

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

Surgery to remove your stomach is called a gastrectomy. There are different types of gastrectomy. The type you have depends on the stage and position of your cancer. You might have: a subtotal or ...

Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

e-Fuels leader approved for Tier II design pathway under California LCFS HOUSTON, March 11, 2025 /PRNewswire/ -- HIF Global, the leader in highly innovative fuels, is proud to announce that it has ...

A genetic mutation in the lungs can cause non-small cell lung cancer (NSCLC). Different mutations can affect your treatment decisions and outcomes. Genetic testing after a diagnosis of NSCLC is ...

Treatment-related adverse events (TRAEs) with ivonescimab were consistent with known toxicities of PD-L1 and VEGF inhibitors ... in non-oncogene-driven locally advanced or metastatic NSCLC with ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

There are various types of this disease. Non-small cell lung cancer (NSCLC) is a disease where cancer cells develop slowly in the lung. Adenocarcinoma is the most common form of lung cancer and begins ...

Mutations or silencing of the von Hippel Lindau (VHL) tumor suppressor gene accumulates hypoxia-inducible factors (HIFs). HIF-2α is implicated in the oncogenesis of ~50% of patients with clear cell ...